Cloning and characterization of a bovine adeno-associated virus

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6509-6516

  Schmidt, Michael ^a   Katano, Hisako ^a   Bossis, Ioannis ^a   Chiorini, John A ^a,b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 4; ADENO ASSOCIATED VIRUS 5; ANIMAL CELL; ARTICLE; BOVINE ADENOVIRUS; BOVINE ADENOVIRUS ASSOCIATED VIRUS; GENE TRANSFER; HUMAN; HUMAN CELL; INVERTED TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SALIVARY GLAND; SEROTYPE; VIRAL CONTAMINATION; VIRUS CAPSID; VIRUS CHARACTERIZATION; VIRUS ISOLATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE; CLONING, MOLECULAR; DEPENDOVIRUS; DNA-BINDING PROTEINS; GENETIC VECTORS; GENOME, VIRAL; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLANT PROTEINS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

EID: 2642528483     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6509-6516.2004     Document Type: Article

References (35)

1. Badgett, M. R., A. Auer, L. E. Carmichael, C. R. Parrish, and J. J. Bull. 2002. Evolutionary dynamics of viral attenuation. J. Virol. 76:10524-10529.
2. Baum, B. J., and B. C. O'Connell. 1999. In vivo gene transfer to salivary glands. Crit. Rev. Oral Biol. Med. 10:276-283.
3. Baum, B. J., R. B. Wellner, and C. Zheng. 2002. Gene transfer to salivary glands. Int. Rev. Cytol. 213:93-146.
4. Berns, K. I. 1990. Parvovirus replication. Microbiol. Rev. 54:316-329.
5. Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. 1967. Isolation of adenovirus-associated viruses from man. Proc. Natl. Acad. Sci. USA 58:1410-1415.
6. Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. 1968. Serologic evidence for human infection with adenovirus-associated viruses. J. Natl. Cancer Inst. 40:319-327.
7. Bossis, I., and J. A. Chiorini. 2003. Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J. Virol. 77:6799-6810.
8. Chiorini, J. A., F. Kim, L. Yang, and R. M. Kotin. 1999. Cloning and characterization of adeno-associated virus type 5. J. Virol. 73:1309-1319.
9. Chiorini, J. A., L. Yang, Y. Liu, B. Safer, and R. M. Kotin. 1997. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol. 71:6823-6833.
10. Coria, M. F., and H. D. Lehmkuhl. 1978. Isolation and identification of a bovine adenovirus type 3 with an adenovirus-associated virus. Am. J. Vet. Res. 39:1904-1906.
11. Davis, M. D., J. Wu, and R. A. Owens. 2000. Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J. Virol. 74:2936-2942.
12. Erles, K., P. Sebokova, and J. R. Schlehofer. 1999. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J. Med. Virol. 59:406-411.
13. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
14. Fisher, K. J., G. P. Gao, M. D. Weitzman, R. DeMatteo, J. F. Burda, and J. M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
15. Gao, G. P., M. R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J. M. Wilson. 2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99:11854-11859.
16. Hickman, A. B., D. R. Ronning, R. M. Kotin, and F. Dyda. 2002. Structural unity among viral origin binding proteins: crystal structure of the nuclease domain of adeno-associated virus. Rep. Mol. Cell 10:327-337.
17. Hoggan, M. D. 1970. Adenovirus associated viruses. Prog. Med. Virol. 12:211-239.
18. Katano, H., S. Afione, M. Schmidt, and J. A. Chiorini. 2004. Identification of adeno-associated virus contamination in cell and virus stocks by PCR. Biotechniques 36:1-4.
19. Laughlin, C. A., H. Westphal, and B. J. Carter. 1979. Spliced adenovirus-associated virus RNA. Proc. Natl. Acad. Sci. USA 76:5567-5571.
20. Luchsinger, E., R. Strobbe, G. Wellemans, D. Dekegel, and S. Sprecher-Goldberger. 1970. Haemagglutinating adeno-associated virus (AAV) in association with bovine adenovirus type 1. Brief report. Arch. Gesamte Virus-forsch. 31:390-392.
21. Lusby, E. W., and K. I. Berns. 1982. Mapping of the 5′ termini of two adeno-associated virus 2 RNAs in the left half of the genome. J. Virol. 41:518-526.
22. Muralidhar, S., S. P. Becerra, and J. A. Rose. 1994. Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity. J. Virol. 68:170-176.
23. Muramatsu, S., H. Mizukami, N. S. Young, and K. E. Brown. 1996. Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 221:208-217.
24. Myrup, A. C., S. B. Mohanty, and F. M. Hetrick. 1976. Isolation and characterization of adeno-associated viruses from bovine adenovirus types 1 and 2. Am. J. Vet. Res. 37:907-910.
25. Owens, R. A., M. D. Weitzman, S. R. Kyostio, and B. J. Carter. 1993. Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J. Virol. 67:997-1005.
26. Qiu, J., R. Nayak, G. E. Tullis, and D. J. Pintel. 2002. Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses. J. Virol. 76:12435-12447.
27. Redemann, B. E., E. Mendelson, and B. J. Carter. 1989. Adeno-associated virus Rep protein synthesis during productive infection. J. Virol. 63:873-882.
28. Rose, J. A., J. V. Maizel, Jr., J. K. Inman, and A. J. Shatkin. 1971. Structural proteins of adenovirus-associated viruses. J. Virol. 8:766-770.
29. Rutledge, E. A., C. L. Halbert, and D. W. Russell. 1998. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72:309-319.
30. Samulski, R. J., K. I. Berns, M. Tan, and N. Muzyczka. 1982. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 79:2077-2081.
31. Smith, R. H., S. A. Afione, and R. M. Kotin. 2002. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid. BioTechniques 33:204-206, 208, 210-211.
32. Smith, R. H., and R. M. Kotin. 1998. The Rep52 gene product of adeno-associated virus is a DNA helicase with 3′-to-5′ polarity. J. Virol. 72:4874-4881.
33. Srivastava, A., E. W. Lusby, and K. I. Berns. 1983. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45:555-564.
34. Xiao, W., N. Chirmule, S. C. Berta, B. McCullough, G. Gao, and J. M. Wilson. 1999. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73:3994-4003.
35. Yamano, S., L. Y. Huang, C. Ding, J. A. Chiorini, C. M. Goldsmith, R. B. Wellner, B. Golding, R. M. Kotin, D. E. Scott, and B. J. Baum. 2002. Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum. Gene Ther. 13:287-298.